WorldQuant Millennium Advisors
CRL icon

WorldQuant Millennium Advisors’s Charles River Laboratories CRL Stock Holding History

WorldQuant Millennium Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,768
Closed -$3.28M – 501
2025
Q1 		$3.28M Sell
21,768
-110,658
-84% -$18.6M 0.02% 323
2024
Q4 		$24.4M Buy
+132,426
New +$25.5M 0.16% 155
2023
Q4 		– Sell
-21,473
Closed -$4.21M – 349
2023
Q3 		$4.21M Buy
21,473
+9,257
+76% +$1.9M 0.07% 237
2023
Q2 		$2.57M Buy
+12,216
New +$2.43M 0.04% 282

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

WorldQuant Millennium Advisors's CRL Position: Q2 2025 in Review

WorldQuant Millennium Advisors sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 21,768 shares — an estimated $3.28M sold.

WorldQuant Millennium Advisors first reported a position in CRL in Q2 2023 and held it in 4 quarters. The position peaked at $24.4M in Q4 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • WorldQuant Millennium Advisors reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 21,768 Charles River Laboratories shares in Q2 2025, an estimated $3.28M.
  • WorldQuant Millennium Advisors first reported a position in Charles River Laboratories in Q2 2023 and held it in 4 quarters.
  • WorldQuant Millennium Advisors's Charles River Laboratories position peaked at $24.4M in Q4 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.